Cite Filings / DMRA / 9999999995-21-004331

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Damora Therapeutics, Inc. Filed 2021-11-12 Acc 9999999995-21-004331

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2025-12-23 EFFECT Notice of Effectiveness
2021-11-12 EFFECT Notice of Effectiveness
2021-11-10 CORRESP Correspondence Between Filers and SEC Staff
2021-11-10 4 Chief Executive Officer bought 4,500 shares at $3.50 ($15,750)
2021-11-10 UPLOAD SEC-generated Letter
2021-11-09 4 Chief Financial Officer bought 3,000 shares at $3.40 ($10,200)
2020-10-28 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…